Titlebook: Obsessive-Compulsive Symptoms in Schizophrenia; Lieuwe De Haan,Frederike Schirmbeck,Mathias Zink Book 2015 Springer International Publishi

武器

Susanne Englisch MD,Mathias Zink MDerigen Betrachtungen gegenüber, die sich mit dem ?Wechsel des Koordinatensystems“ befassen, doch ist die innige Durchdringung beider Gebiete nicht zu verkennen und die Trennung im vorhergehenden auch nicht immer scharf durchgeführt worden. Wir haben als Grundlage der Untersuchung auf der einen Seite

dilute

Epidemiology: Prevalence and Clinical Characteristics of Obsessive-Compulsive Disorder and Obsessivengitudinal course of symptoms over time, subgroups within the co-morbid sample are defined. In order to validate the proposed subcategorization, further prospective research is needed to investigate pathogenic mechanisms, including the influence of genetic, environmental and individual factors, as w

conference

Obsessive-Compulsive Disorder with Schizotypal Personality Disorder (Schizotypal OCD)om their random co-occurrence. It is estimated that roughly a quarter of schizophrenia patients also have obsessive-compulsive symptoms (OCS), with 10–15 % meeting the diagnostic criteria for OCD..The interface of obsessive-compulsive and schizophrenic phenomena is not limited to the co-occurrence o

創(chuàng)造性

Duodenitis

完成

Gene–Environment Interactions in the Pathogenesis of Obsessive–Compulsive Symptoms in Schizophreniahizophrenia. For performing future large-scale multicenter studies, replication studies, and meta-analyses, valid and applicable research criteria for different subtypes of OCSs in schizophrenia are needed. In addition, more clinical attention on this manifestation would be important for the progres

alliance

Effects of Antipsychotic Treatment on Obsessive-Compulsive Symptomsatterns of brain activation during functional magnetic resonance imaging using OCS-sensitive tasks. Specific genetic risk factors seem to dispose patients with schizophrenia to develop OCS during SGA treatment. Further research is needed to investigate possible gene and environment interactions in m

CESS

Polypharmacy for Obsessive-Compulsive Symptoms in Schizophrenia: Augmentation and Combination Strate. In such cases, symptomatic improvement could be achieved by dose reductions of clozapine when combined with other SGAs such as aripiprazole..The current level of evidence is limited by the lack of placebo- or comparator-controlled studies. Thus, the efficacy and tolerability of different pharmacol

AGGER

Cognitive Behavioural Therapy for Co-occurring Obsessive-Compulsive Symptoms for OCS in schizophrenia. Based on these findings and with a strong focus on tolerability concerns, we outline a modular CBT approach. Further research within this field and evaluations in controlled clinical trials are highly desirable.

Counteract